Related Experiment Video
Updated: Jun 4, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
A case of malignant hyperthermia during anesthesia induction with sevoflurane -A case report-
Yoon Sook Lee1, Woon Young Kim, Se Hwa Lee
1Department of Anesthesiology and Pain Medicine, Korea University Ansan Hospital, Ansan, Korea.
Abstract:
We experienced a case of malignant hyperthermia (MH) in 6-year-old boy during anesthesia induction for strabismus surgery. It has been generally reported that sevoflurane can induce the delayed onset of MH in the absence of succinylcholine. Our case of MH was elicited after about 2-3 min of sevoflurane administration with N(2)O, O(2) and rocuronium. However, we successfully treated the patient by early recognition of his condition and administering symptomatic treatment and dantrolene.
Insights
Malignant hyperthermia (MH) occurred in a child during anesthesia. Early recognition and treatment with dantrolene successfully managed this rare but serious adverse event.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Malignant hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder of skeletal muscle.
- While often associated with succinylcholine, volatile anesthetics like sevoflurane can also trigger MH, sometimes with delayed onset.
Purpose of the Study:
- To report a case of sevoflurane-induced malignant hyperthermia in a pediatric patient.
- To highlight the importance of early recognition and prompt management of MH during anesthesia.
Main Methods:
- A 6-year-old boy developed MH during anesthesia induction for strabismus surgery.
- Sevoflurane was administered with nitrous oxide, oxygen, and rocuronium.
- The patient received symptomatic treatment and dantrolene.
Main Results:
- Malignant hyperthermia was triggered approximately 2-3 minutes after sevoflurane administration.
- The patient's condition was successfully treated with early recognition and administration of dantrolene and supportive care.
Conclusions:
- Sevoflurane can induce malignant hyperthermia even without succinylcholine.
- Prompt diagnosis and dantrolene administration are critical for successful management of MH.
- Vigilance for MH is essential in pediatric anesthesia, particularly when using volatile agents.
Related Concept Videos
Inhalational Anesthetics: Overview
Increased Body Temperature
Types of Fever
Here are the different types of fever:
Acute Respiratory Failure-III
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
